Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms
- 3 April 2014
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 123 (14), 2220-2228
- https://doi.org/10.1182/blood-2013-11-537167
Abstract
Myeloproliferative neoplasms (MPNs) are a group of clonal disorders characterized by aberrant hematopoietic proliferation and an increased tendency toward leukemic transformation. We used targeted next-generation sequencing (NGS) of 104 genes to detect somatic mutations in a cohort of 197 MPN patients and followed clonal evolution and the impact on clinical outcome. Mutations in calreticulin (CALR) were detected using a sensitive allele-specific polymerase chain reaction. We observed somatic mutations in 90% of patients, and 37% carried somatic mutations other than JAK2 V617F and CALR. The presence of 2 or more somatic mutations significantly reduced overall survival and increased the risk of transformation into acute myeloid leukemia. In particular, somatic mutations with loss of heterozygosity in TP53 were strongly associated with leukemic transformation. We used NGS to follow and quantitate somatic mutations in serial samples from MPN patients. Surprisingly, the number of mutations between early and late patient samples did not significantly change, and during a total follow-up of 133 patient years, only 2 new mutations appeared, suggesting that the mutation rate in MPN is rather low. Our data show that comprehensive mutational screening at diagnosis and during follow-up has considerable potential to identify patients at high risk of disease progression.This publication has 34 references indexed in Scilit:
- Inherited predisposition to myeloproliferative neoplasmsTherapeutic Advances in Hematology, 2013
- Mutations and prognosis in primary myelofibrosisLeukemia, 2013
- MPN patients harbor recurrent truncating mutations in transcription factor NF-E2The Journal of Experimental Medicine, 2013
- Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesisNature Genetics, 2012
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid LeukemiaThe New England Journal of Medicine, 2012
- New mutations and pathogenesis of myeloproliferative neoplasmsBlood, 2011
- JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F–positive essential thrombocythemiaBlood, 2010
- Genetic Analysis of Transforming Events That Convert Chronic Myeloproliferative Neoplasms to LeukemiasCancer Research, 2010
- Mutation inTET2in Myeloid CancersThe New England Journal of Medicine, 2009
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005